Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • blancha
    Senior Member
    • May 2013
    • 367

    #16
    From the software point of view, the biggest question will be whether you want to install a queuing system, with TORQUE and Moab for example.

    As GenoMax has pointed out, cluster administration is not trivial, and the biggest expense may be the salary of the personnel to administrate the cluster.

    I really think off-site computing or cloud computing is the ideal solution for next-generation sequencing analysis. The administration of the cluster is then no longer your responsibility.

    It may not always be possible however to do this at a reasonable cost. In Canada, researchers are provided access to computing clusters at no cost. I'm not sure how this could be done in other countries. For example, I wonder if it it cost feasible to use only Amazon Web Services. Perhaps not.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #17
      @blancha: @cmccabe works in a hospital so local security policy/HIPAA restrictions would most likely restrict/nix use of any external cloud based resources (unless the companies are willing to enter into business agreements).

      @cmccabe does seem to have access to central IT but as you and I have pointed out this would add workload to their plate and would require them to acquire cluster admin expertise. It will depend on how good a salesperson @cmccabe is when talking with them.

      For reference this question has now been posted on Biostars: https://www.biostars.org/p/167118/

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Working...